-
1
-
-
0035970668
-
Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination antiretroviral therapy
-
Grulich AE, Li YM, McDonald AM, Correll PK, Law MG, Kaldor JM. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination antiretroviral therapy. AIDS 2001;15:629-33.
-
(2001)
AIDS
, vol.15
, pp. 629-633
-
-
Grulich, A.E.1
Li, Y.M.2
McDonald, A.M.3
Correll, P.K.4
Law, M.G.5
Kaldor, J.M.6
-
2
-
-
33746871449
-
Pathogenesis of AIDS lymphoma: Role of oncogenic viruses and B cell activation- Associated molecular lesions
-
Epeldegui M, Widney DP, Martinez-Maza O. Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation- Associated molecular lesions. Curr Opin Oncol 2006;18: 444-8.
-
(2006)
Curr Opin Oncol
, vol.18
, pp. 444-448
-
-
Epeldegui, M.1
Widney, D.P.2
Martinez-Maza, O.3
-
3
-
-
79951534338
-
Assessment of pre-diagnosis biomarkers of immune activation and inflammation: Insights on the etiology of lymphoma
-
Vendrame E, Martiínez-Maza O. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma. J Proteome Res 2010;10:113-9.
-
(2010)
J Proteome Res
, vol.10
, pp. 113-119
-
-
Vendrame, E.1
Martiínez-Maza, O.2
-
4
-
-
84872345652
-
Markers of microbial translocation and risk of AIDS-related lymphoma
-
Marks MA, Rabkin CS, Engels EA, Busch E, Kopp W, Rager H, et al. Markers of microbial translocation and risk of AIDS-related lymphoma. AIDS 2013;27:469-74.
-
(2013)
AIDS
, vol.27
, pp. 469-474
-
-
Marks, M.A.1
Rabkin, C.S.2
Engels, E.A.3
Busch, E.4
Kopp, W.5
Rager, H.6
-
5
-
-
0037881911
-
Constitutive expression of AID leads to tumorigenesis
-
Okazaki I, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003;197:1173-81.
-
(2003)
J Exp Med
, vol.197
, pp. 1173-1181
-
-
Okazaki, I.1
Hiai, H.2
Kakazu, N.3
Yamada, S.4
Muramatsu, M.5
Kinoshita, K.6
-
6
-
-
77952428846
-
AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model
-
Komeno Y, Kitaura J, Watanabe-Okochi N, Kato N, Oki T, Nakahara F, et al. AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model. Leukemia 2010;24:1018-24.
-
(2010)
Leukemia
, vol.24
, pp. 1018-1024
-
-
Komeno, Y.1
Kitaura, J.2
Watanabe-Okochi, N.3
Kato, N.4
Oki, T.5
Nakahara, F.6
-
7
-
-
84873374765
-
Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin Bcell lymphoma risk
-
Hussain SK, Zhu W, Chang S-C, Breen EC, Vendrame E, Magpantay L, et al. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin Bcell lymphoma risk. Cancer Epidemiol Biomarkers Prev 2013;22: 295-307.
-
(2013)
Cancer Epidemiol Biomarkers Prev
, vol.22
, pp. 295-307
-
-
Hussain, S.K.1
Zhu, W.2
Chang, S.-C.3
Breen, E.C.4
Vendrame, E.5
Magpantay, L.6
-
8
-
-
80052873061
-
Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma
-
Rabkin CS, Engels EA, Landgren O, Schuurman R, Camargo MC, Pfeiffer R, et al. Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma. Am J Hematol 2011;86:875-8.
-
(2011)
Am J Hematol
, vol.86
, pp. 875-878
-
-
Rabkin, C.S.1
Engels, E.A.2
Landgren, O.3
Schuurman, R.4
Camargo, M.C.5
Pfeiffer, R.6
-
9
-
-
77649208373
-
Circulating serum free light chains as predictive markers of AIDSrelated lymphoma
-
Landgren O, Goedert JJ, Rabkin CS, Wilson WH, Dunleavy K, Kyle RA, et al. Circulating serum free light chains as predictive markers of AIDSrelated lymphoma. J Clin Oncol 2010;28:773-9.
-
(2010)
J Clin Oncol
, vol.28
, pp. 773-779
-
-
Landgren, O.1
Goedert, J.J.2
Rabkin, C.S.3
Wilson, W.H.4
Dunleavy, K.5
Kyle, R.A.6
-
10
-
-
37349024988
-
Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-NHL diagnosis
-
Epeldegui M, Breen EC, Hung YP, Boscardin WJ, Detels R, Martinez- Maza O. Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-NHL diagnosis. AIDS 2007;21:2265-70.
-
(2007)
AIDS
, vol.21
, pp. 2265-2270
-
-
Epeldegui, M.1
Breen, E.C.2
Hung, Y.P.3
Boscardin, W.J.4
Detels, R.5
Martinez-, M.O.6
-
11
-
-
79960102823
-
B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-hodgkin B-cell lymphoma
-
Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, et al. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-hodgkin B-cell lymphoma. Cancer Epidemiol Biomarkers Prev 2011;20:1303-14.
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, pp. 1303-1314
-
-
Breen, E.C.1
Hussain, S.K.2
Magpantay, L.3
Jacobson, L.P.4
Detels, R.5
Rabkin, C.S.6
-
12
-
-
70350490588
-
A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma
-
Purdue MP, Lan Q, Martinez-Maza O, Oken MM, Hocking W, Huang WY, et al. A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. Blood 2009;114:2730-2.
-
(2009)
Blood
, vol.114
, pp. 2730-2732
-
-
Purdue, M.P.1
Lan, Q.2
Martinez-Maza, O.3
Oken, M.M.4
Hocking, W.5
Huang, W.Y.6
-
13
-
-
79551583111
-
Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation
-
Regidor DL, Detels R, Breen EC, Widney DP, Jacobson LP, Palella F, et al. Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS 2011;25: 303-14.
-
(2011)
AIDS
, vol.25
, pp. 303-314
-
-
Regidor, D.L.1
Detels, R.2
Breen, E.C.3
Widney, D.P.4
Jacobson, L.P.5
Palella, F.6
-
14
-
-
0031942881
-
The women's interagency HIV study
-
Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The women's interagency HIV study. Epidemiology 1998;9: 117-25.
-
(1998)
Epidemiology
, vol.9
, pp. 117-125
-
-
Barkan, S.E.1
Melnick, S.L.2
Preston-Martin, S.3
Weber, K.4
Kalish, L.A.5
Miotti, P.6
-
15
-
-
24944575162
-
The women's interagency HIV study: An observational cohort brings clinical sciences to the Bench
-
Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, et al. The women's interagency HIV study: An observational cohort brings clinical sciences to the Bench. Clin Diagn Lab Immunol 2005;12: 1013-9.
-
(2005)
Clin Diagn Lab Immunol
, vol.12
, pp. 1013-1019
-
-
Bacon, M.C.1
Von, W.V.2
Alden, C.3
Sharp, G.4
Robison, E.5
Hessol, N.6
-
17
-
-
34547130845
-
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
-
Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110: 695-708.
-
(2007)
Blood
, vol.110
, pp. 695-708
-
-
Morton, L.M.1
Turner, J.J.2
Cerhan, J.R.3
Linet, M.S.4
Treseler, P.A.5
Clarke, C.A.6
-
18
-
-
0026643305
-
Generalized linear models with random effects; salamander mating revisited
-
Karim MR, Zeger SL. Generalized linear models with random effects; salamander mating revisited. Biometrics 1992;48:631-44.
-
(1992)
Biometrics
, vol.48
, pp. 631-644
-
-
Karim, M.R.1
Zeger, S.L.2
-
21
-
-
84866421141
-
Markers of B-cell activation in relation to risk of non-hodgkin lymphoma
-
DeRoos AJ, Mirick DK, Edlefsen KL, LaCroix AZ, Kopecky KJ, Madeleine MM, et al. Markers of B-cell activation in relation to risk of non-hodgkin lymphoma. Cancer Res 2012;72:4733-43.
-
(2012)
Cancer Res
, vol.72
, pp. 4733-4743
-
-
De Roos, A.J.1
Mirick, D.K.2
Edlefsen, K.L.3
Lacroix, A.Z.4
Kopecky, K.J.5
Madeleine, M.M.6
-
22
-
-
0034001168
-
Memory B cells and CD27
-
Agematsu K. Memory B cells and CD27. Histol Histopathol 2000; 15:573-6.
-
(2000)
Histol Histopathol
, vol.15
, pp. 573-576
-
-
Agematsu, K.1
-
23
-
-
0034987619
-
The role of CD30 in atopic disease
-
Bengtsson A. The role of CD30 in atopic disease. Allergy 2001;56: 593-603.
-
(2001)
Allergy
, vol.56
, pp. 593-603
-
-
Bengtsson, A.1
-
24
-
-
0029017634
-
Circulating levels of soluble CD30, a marker of cells producing TH2-type cytokines, are increased in patients with systemic lupus-erythematosus and correlate with disease-activity
-
Caligariscappio F, Bertero MT, Converso M, Stacchini A, Vinante F, Romagnani S, et al. Circulating levels of soluble CD30, a marker of cells producing TH2-type cytokines, are increased in patients with systemic lupus-erythematosus and correlate with disease-activity. Clin Exp Rheumatol 1995;13:339-43.
-
(1995)
Clin Exp Rheumatol
, vol.13
, pp. 339-343
-
-
Caligariscappio, F.1
Bertero, M.T.2
Converso, M.3
Stacchini, A.4
Vinante, F.5
Romagnani, S.6
-
25
-
-
0034060161
-
Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease
-
Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, et al. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease. J Rheumatol 2000;27:698-702.
-
(2000)
J Rheumatol
, vol.27
, pp. 698-702
-
-
Ihn, H.1
Yazawa, N.2
Kubo, M.3
Yamane, K.4
Sato, S.5
Fujimoto, M.6
-
26
-
-
65349144269
-
Timing and tuning of CD27-CD70 interactions: The impact of signal strength in setting the balance between adaptive responses and immunopathology
-
Nolte MA, vanOlffen RW, vanGisbergen K, vanLier RAW. Timing and tuning of CD27-CD70 interactions: The impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 2009;229:216-31.
-
(2009)
Immunol Rev
, vol.229
, pp. 216-231
-
-
Nolte, M.A.1
Van Olffen, R.W.2
Van Gisbergen, K.3
Van Lier, R.A.W.4
-
27
-
-
0032716260
-
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma
-
Widney D, Gundapp G, Said JW, van der Meijden M, Bonavida B, Demidem A, et al. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol 1999;93:114-23.
-
(1999)
Clin Immunol
, vol.93
, pp. 114-123
-
-
Widney, D.1
Gundapp, G.2
Said, J.W.3
Van, D.M.M.4
Bonavida, B.5
Demidem, A.6
-
28
-
-
0032536373
-
B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5
-
Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998;187:655-60.
-
(1998)
J Exp Med
, vol.187
, pp. 655-660
-
-
Legler, D.F.1
Loetscher, M.2
Roos, R.S.3
Clark-Lewis, I.4
Baggiolini, M.5
Moser, B.6
-
29
-
-
0034691531
-
A chemokine-driven positive feedback loop organizes lymphoid follicles
-
Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000;406:309-14.
-
(2000)
Nature
, vol.406
, pp. 309-314
-
-
Ansel, K.M.1
Ngo, V.N.2
Hyman, P.L.3
Luther, S.A.4
Forster, R.5
Sedgwick, J.D.6
-
30
-
-
0037034880
-
Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position
-
Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, Forster R, et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002;416:94-9.
-
(2002)
Nature
, vol.416
, pp. 94-99
-
-
Reif, K.1
Ekland, E.H.2
Ohl, L.3
Nakano, H.4
Lipp, M.5
Forster, R.6
-
31
-
-
29444460178
-
Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection
-
Widney DP, Breen EC, Boscardin WJ, Kitchen SG, Alcantar JM, Smith JB, et al. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J Interferon Cytokine Res 2005; 25:702-6.
-
(2005)
J Interferon Cytokine Res
, vol.25
, pp. 702-706
-
-
Widney, D.P.1
Breen, E.C.2
Boscardin, W.J.3
Kitchen, S.G.4
Alcantar, J.M.5
Smith, J.B.6
-
32
-
-
0028228915
-
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS
-
Pizzolo G, Vinante F, Morosato L, Nadali G, Chilosi M, Gandini G, et al. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 1994;8:741-6.
-
(1994)
AIDS
, vol.8
, pp. 741-746
-
-
Pizzolo, G.1
Vinante, F.2
Morosato, L.3
Nadali, G.4
Chilosi, M.5
Gandini, G.6
-
33
-
-
0032824853
-
The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6
-
Crabb Breen E, van der Meijden M, Cumberland W, Kishimoto T, Detels R, Mart, et al. The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6. Clin Immunol 1999;92:293-9.
-
(1999)
Clin Immunol
, vol.92
, pp. 293-299
-
-
Crabb, B.E.1
Van Der Meijden, M.2
Cumberland, W.3
Kishimoto, T.4
Detels, R.5
Mart6
-
34
-
-
0028963809
-
Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma
-
Yawetz S, Cumberland W, van der Meyden M, Martinez-Maza O. Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma. Blood 1995;85:1843-9.
-
(1995)
Blood
, vol.85
, pp. 1843-1849
-
-
Yawetz, S.1
Cumberland, W.2
Van Der, MeydenM.3
Martinez-Maza, O.4
-
35
-
-
0032801865
-
Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue
-
Schroeder JR, Saah AJ, Ambinder RF, Martinez-Maza O, Breen EC, Variakojis D, et al. Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue. Clin Immunol 1999;93:239-44.
-
(1999)
Clin Immunol
, vol.93
, pp. 239-244
-
-
Schroeder, J.R.1
Saah, A.J.2
Ambinder, R.F.3
Martinez-Maza, O.4
Breen, E.C.5
Variakojis, D.6
-
36
-
-
3042732190
-
Medically eligible women who do not use HAART: The importance of abuse, drug use, and race
-
Cohen MH, Cook JA, Grey D, Young M, Hanau LH, Tien P, et al. Medically eligible women who do not use HAART: The importance of abuse, drug use, and race. Am J Public Health 2004;94:1147-51.
-
(2004)
Am J Public Health
, vol.94
, pp. 1147-1151
-
-
Cohen, M.H.1
Cook, J.A.2
Grey, D.3
Young, M.4
Hanau, L.H.5
Tien, P.6
|